Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis (gMG) in adults who ...
23h
“It’s Called The Mammalian Dive Reflex”: 50 Facts About The Human Body That Sound Fake But Aren’t
One of the biggest mistakes you can make in life is believing that you know everything there is to know. Even if you’re ...
Discusses ABS-201 Program and Clinical Approach for Androgenetic Alopecia December 11, 2025 10:00 AM ESTCompany ...
Working together, nuclear power and AI could help create a sustainable future, but this requires responsible development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback